NEIL RIORDAN, P.A. is the Founder of Aidan Incorporated and the Aidan Clinic in Tempe, AZ. He holds 5 U.S. and international patents and has 7 patents pending. Mr. Riordan has co-authored articles on High-Dose Vitamin C, Novel Angiogenesis Inhibitors and Immunotherapeutic Agents for cancer, published in prestigious medical journals including British Journal of Cancer, AntiCancer Research, Journal of Orthomolecular Medicine and Medical Hypotheses.
Mr. Riordan received his B.S. Degree in Physician Assistant Studies, magna cum laude, from Wichita State University, Kansas and his Masterís Degree in Physician Assistant Studies (P.A.) from the University of Nebraska School of Medicine, Omaha. He was the Senior Research Scientist and Project Manager for Project RECNAC at the Biocommunications Research Institute from 1989 through 1999.
At present, Mr. Riordan is a member of the American Society for Microbiology, Kansas Academy of Physician Assistants, American Academy of Physician Assistants, and the American Chemical Society. He also was a member of the International Society for Nutrition and Cancer in 1997.
Currently, Mr. Riordan is the President and CEO of Aidan Clinic and Aidan Incorporated and is responsible for the research and development of protocols and therapies used there. Aidan Clinic is a research-based facility providing comprehensive care for people with cancer. Aidan Incorporated product line includes the dietary supplements C-Statin, Imm-Kine, and IVC-Max. He can be contacted at (480) 466-8181 or e-mail at email@example.com.
Mr. Riordan will speak on The Effects Of New Angiogenesis Inhibitors And High Dose Vitamin C For Cancer Patients.